3 Uranium Stocks Worth Buying as Nuclear Heats up in June

Uranium prices remain firm, with long-term pricing near $91.50/lb and spot up 34% year over year to $88.49/lb, supporting producers and enrichers. Cameco posted strong Q1 operating results and reaffirmed 2026 guidance, while Centrus beat EPS expectations by 289% and raised full-year revenue guidance to $450 million-$500 million. The article is constructive for the uranium and nuclear supply chain, though execution and supply risks remain for individual names.

Analysis

The market is no longer pricing uranium as a simple commodity beta trade; it’s increasingly valuing balance-sheet durability and contract duration. That favors the names with conversion power from rising realized prices into cash flow, while weaker operators without long-term coverage will lag even if spot keeps grinding higher. The second-order winner is the fuel-cycle ecosystem: more capital flowing into reactors and enrichment should tighten the bottleneck outside the mines, which is why enrichment capacity may re-rate faster than raw uranium exposure over the next 6-12 months.

CCJ looks like the highest-quality way to express the thesis, but the setup is now more about multiple support than pure earnings surprise. With the stock off its highs and guidance already anchored by contracted volumes, upside comes from evidence that realized pricing and Westinghouse contribution are compounding faster than expected; downside is any operational slip that forces the market to haircut the contract book. The unresolved tax dispute and maintenance issues matter less for near-term cash generation than for sentiment, but they create a clean catalyst window into the next quarterly print.

LEU has the more convex risk/reward because the market is underwriting execution risk heavily while the policy backdrop is doing the valuation work. If DOE/NNSA support stays intact, the stock can re-rate quickly on confirmation of sole-source visibility and construction milestones; if appropriations slip or policy direction changes, the equity can de-rate sharply because the backlog does not eliminate timing risk. The contrarian view is that the market may be overpaying for scarcity in the enrichment narrative and underestimating how quickly a policy headline can compress multiples in a namespaced, subsidy-dependent business.

URA is useful as a cleaner expression of the sector call, but it is the least efficient vehicle if the objective is alpha generation. It gives up upside capture in the best operators and still leaves investors exposed to commodity drawdowns, so it’s more of a parking place for tactical capital than a high-conviction expression. Meta and the broader AI-power theme matter only as a demand-duration amplifier; they justify the secular narrative, but the near-term trade still lives or dies on contract pricing and government execution, not on incremental megawatt headlines.

Key Decisions for Investors

• Long CCJ into the next 4-6 weeks, targeting July 31 earnings as the catalyst; use the recent pullback as entry and size for a 15-20% rebound if realized pricing and Westinghouse contribution track higher, with a hard stop if guidance credibility weakens.
• Buy LEU on strength only after confirmation of the Certified for Construction package / NNSA sole-source clarity; this is a higher-beta 3-9 month trade with asymmetric upside, but cut exposure if execution milestones slip or DOE policy noise increases.
• Use URA as a basket hedge, not the main expression: long URA against short broader industrial/clean-energy beta if you want sector exposure with lower single-name risk, but expect it to underperform CCJ/LEU in a rising-fundamentals tape.
• Pair trade: long CCJ / short lower-quality uranium miners or unloved fuel-cycle peers for 6-12 months; the thesis is that contract coverage and balance-sheet quality will compound while weaker names lag on funding and operational risk.
• For options, consider CCJ call spreads into the July 31 print rather than outright equity; it limits valuation risk if the market starts discounting any guidance miss, while preserving upside from a stronger realized-price update.